Pluristem Therapeutics (PSTI) Reports 75% Complete ENrollment in Pivotal Phase III CLI Clinical Study - StreetInsider.com Get link Facebook X Pinterest Email Other Apps December 18, 2019 Pluristem Therapeutics (PSTI) Reports 75% Complete ENrollment in Pivotal Phase III CLI Clinical Study StreetInsider.com Get link Facebook X Pinterest Email Other Apps Comments
Comments
Post a Comment